Literature DB >> 11040076

Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis.

N R Ratcliffe1, J Hutchins, B Barry, W F Hickey.   

Abstract

Recent recognition that an autoimmune myocarditis may precede, and result in, dilated cardiomyopathy has focused attention on immune mechanisms of myocardial injury. In this paper, we describe a model of chronic autoimmune myocarditis in the Lewis rat. The production of myocarditis has been previously described by this group and in brief is accomplished by a single tail vein infusion of activated T cells specific for a 17-amino acid peptide from rat cardiac myosin. In this report, animals were followed for approximately 6 months post-T-cell infusion. Hearts from animals which received cardiac myosin specific T cells all showed extensive fibrosis associated with ongoing inflammation. Apoptosis, identified by TdT-mediated dUTP nick end labelling (TUNEL), was identified as a mode of myocyte death in hearts with acute and chronic myocarditis but not in age- and sex-matched controls. Immunohistochemistry was used to characterize the immune infiltrate and adhesion molecules in hearts with chronic myocarditis and these findings were compared to hearts with acute myocarditis. We propose that this rat model of chronic myocarditis mimics human disease, since inflammation results in ventricular dilatation and myocyte hypertrophy reminiscent of dilated cardiomyopathy. This model offers potential for further investigation of immune, functional and possible therapeutic aspects of autoimmune related cardiomyopathies. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040076     DOI: 10.1006/jaut.2000.0432

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.

Authors:  Abishek Iyer; Andrew Fenning; Junxian Lim; Giang T Le; Robert C Reid; Maria A Halili; David P Fairlie; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

Review 2.  The role of sex differences in autophagy in the heart during coxsackievirus B3-induced myocarditis.

Authors:  Andreas Koenig; Adam Sateriale; Ralph C Budd; Sally A Huber; Iwona A Buskiewicz
Journal:  J Cardiovasc Transl Res       Date:  2013-12-10       Impact factor: 4.132

3.  An experimental model of autoimmune pancreatitis in the rat.

Authors:  Todd S Davidson; Daniel S Longnecker; William F Hickey
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

4.  Analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in anti-CD4 monoclonal antibody treated mice with autoimmune cardiomyopathy.

Authors:  Zhaohui Wang; Yuhua Liao; Jing Yuan; Jinghui Zhang; Jihua Dong; Jinping Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

5.  Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.

Authors:  Lijuan Li; Nan Li; Wei Pang; Xu Zhang; Bruce D Hammock; Ding Ai; Yi Zhu
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

Review 6.  Different effects of prolonged β-adrenergic stimulation on heart and cerebral artery.

Authors:  Eunji Shin; Kyung Soo Ko; Byoung Doo Rhee; Jin Han; Nari Kim
Journal:  Integr Med Res       Date:  2014-10-13

7.  Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis.

Authors:  Yuka Shiheido-Watanabe; Yasuhiro Maejima; Takeshi Kasama; Natsuko Tamura; Shun Nakagama; Yusuke Ito; Kenzo Hirao; Mitsuaki Isobe; Tetsuo Sasano
Journal:  JACC Basic Transl Sci       Date:  2021-06-09

8.  Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts.

Authors:  Jennifer L McLarty; Jianping Li; Scott P Levick; Joseph S Janicki
Journal:  J Inflamm Res       Date:  2013-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.